Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Diabetic Neuropathy Clinical Trials

A listing of Diabetic Neuropathy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (9) clinical trials

Do you have DIABETES? Do You Suffer from PAIN in Your Feet or Legs? The primary purpose of this study is to research the investigational drug, LY545694, for patients with painful diabetic neuropathy (nerve damage that can cause numbness or painful tingling in parts of the body). Qualified Participants Must: ...

Phase

Currently enrolling in your area! Is your current neuropathic pain treatment providing adequate control of your pain? If NOT, you may interested in learning more about a clinical research trial of an investigational medication that is being evaluated for the treatment of diabetes painful neuropathy. You may be eligible to ...

Phase

Do you suffer from persistent burning, throbbing, or tingling pain in your feet? Are you currently taking medication for this pain?

Phase

This study will see if an investigational drug called NYX-2925 can reduce the nerve pain in the legs and feet associated with painful diabetic peripheral neuropathy.

Phase

The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Treatment induced neuropathy of diabetes (TIND), also referred to as insulin neuritis, is thought to be a rare iatrogenic cause of neuropathy that occurs in the setting of rapid glycemic control in individuals with a history of prolonged hyperglycemia. In a recent paper, the investigators reported that a systematic review ...

Phase

Trazodone in Painful Diabetic Neuropathy

This is a randomized, double-blind, placebo controlled, double-dummy, dose finding, parallel group, multicentre, international, prospective, pilot study. The present study is planned to assess the efficacy and the safety of an 8-week treatment period with low doses of trazodone (30 mg daily or 60 mg total daily, respectively) administered to ...

Phase

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

This is a randomized, double-blind, parallel-group, placebo-controlled, multiple-dose study to assess the efficacy and safety of NYX-2925 in subjects with neuropathic pain associated with diabetic peripheral neuropathy. The study will be a 6 to 9-week study, including a 1-to 4-week (dependent on duration of washout period) Screening Period, followed by ...

Phase